Showing 1 - 20 results of 56 for search '"Breast Neoplasms -- immunology"', query time: 1.03s Refine Results
1
Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression

Authors: Travis Nemkov, Igor Zakharevich, Morag Park, Ori Maller, Thanh T. Pham, Johnathon N. Lakins, Allison P. Drain, J. Matthew Barnes, Olöf Bjarnadottir, Jessica Gruenberg, Irene Acerbi, Alexander S. Barrett, E. Shelley Hwang, Aastha Chauhan, Aqsa Nasir, Tina Gruosso, Zena Werb, Signe Borgquist, Kirk C. Hansen, Hellen Kuasne, Lisa M. Coussens, Brian Ruffell, Peter Kabos, Yunn Yi Chen, Valerie M. Weaver, Andrew C. Nelson

Source: Maller, O, Drain, A P, Barrett, A S, Borgquist, S, Ruffell, B, Zakharevich, I, Pham, T T, Gruosso, T, Kuasne, H, Lakins, J N, Acerbi, I, Barnes, J M, Nemkov, T, Chauhan, A, Gruenberg, J, Nasir, A, Bjarnadottir, O, Werb, Z, Kabos, P, Chen, Y-Y, Hwang, E S, Park, M, Coussens, L M, Nelson, A C, Hansen, K C & Weaver, V M 2021, ' Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression ', Nature Materials, vol. 20, no. 4, pp. 548-559 . https://doi.org/10.1038/s41563-020-00849-5
Nature materials, vol 20, iss 4
Nature materials

Subject Terms: Adult, Biopsy, Breast Neoplasms/immunology, Cell Line, Tumor, Collagen/metabolism, Female, Humans, Middle Aged, Protein-Lysine 6-Oxidase/metabolism, Stromal Cells/metabolism, Tumor-Associated Macrophages/metabolism, macromolecular substances, technology, industry, and agriculture, cardiovascular system, Mechanical Engineering, Mechanics of Materials, Condensed Matter Physics, General Materials Science, General Chemistry, Lysyl hydroxylase, biology.protein, biology, Metastasis, medicine.disease, medicine, Cancer research, Cancer, Lysyl oxidase, Stroma, Stromal cell, Hydroxylysine, chemistry.chemical_compound, chemistry, Immunohistochemistry, Cell Line, Tumor, Stromal Cells, Breast Neoplasms, Collagen, Protein-Lysine 6-Oxidase, Tumor-Associated Macrophages, Breast Cancer, 2.1 Biological and endogenous factors, Nanoscience & Nanotechnology, Article

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b763b8a68e3e138bcaa445e6a01a159
https://pure.au.dk/portal/da/publications/tumourassociated-macrophages-drive-stromal-celldependent-collagen-crosslinking-and-stiffening-to-promote-breast-cancer-aggression(52678664-4d14-494a-868c-fbcbe0843b24).html

2
An Immunomodulatory Gallotanin-Rich Fraction From Caesalpinia spinosa Enhances the Therapeutic Effect of Anti-PD-L1 in Melanoma

Authors: Alfonso Barreto, Paola Lasso, Amaia Martinez-Usatorre, Susana Fiorentino, Alejandra Gomez-Cadena, Alena Donda, Pedro Romero, Claudia Urueña

Source: Frontiers in Immunology, Vol 11 (2020)
Frontiers in immunology, vol. 11, pp. 584959
Frontiers in Immunology

Subject Terms: Immunology, Immunology and Allergy, CD8, Cytotoxic T cell, Immune system, PD-L1, biology.protein, biology, Antibody, T cell, medicine.anatomical_structure, medicine, business.industry, business, Melanoma, medicine.disease, Immunotherapy, medicine.medical_treatment, Cancer research, breast cancer, combined therapy, immunotherapy, natural products, melanoma, P2Et extract, lcsh:Immunologic diseases. Allergy, lcsh:RC581-607, Animals, Antibodies, Monoclonal/immunology, Antineoplastic Agents/immunology, B7-H1 Antigen/immunology, Breast Neoplasms/immunology, CD4-Positive T-Lymphocytes/immunology, CD8-Positive T-Lymphocytes/immunology, Caesalpinia/immunology, Cell Line, Tumor, Cell Proliferation/physiology, Female, Humans, Hydrolyzable Tannins/immunology, Immunity/immunology, Immunologic Factors/immunology, MCF-7 Cells, Melanoma, Experimental/immunology, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Plant Extracts/immunology, Polyphenols/immunology, pd-l1, immune-response, cancer, antitumor, cells, expression, blockade, pathway, breast, immunoresistance, Original Research

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8a6aba6eaf8909975566225f669d5aa
https://doi.org/10.3389/fimmu.2020.584959

3
Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma

Authors: Jean-Christophe Tille, André Filipe Vieira, Youlia Kirova, François-Clément Bidard, Laëtitia Furhmann, Lounes Djerroudi, Caroline Saint-Martin, Matthieu Carton, Anne Vincent-Salomon, F Reyal, Anne Tardivon

Contributors: Hôpitaux Universitaires de Genève (HUG), Institut Curie [Paris], Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Universidade do Porto, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Fundo Regional para a Ciência e Tecnologia, FRCT, Funding AFV received support from a Mayent-Rothschild fellowship from Institut Curie, France and IPATIMUP/Fundação para a Ciência e Tecnologia, Portugal.

Source: Modern Pathology
Modern Pathology, Nature Publishing Group: Open Access Hybrid Model Option B, 2020, 33 (11), pp.2198-2207. ⟨10.1038/s41379-020-0561-9⟩
Modern pathology, Vol. 33, No 11 (2020) pp. 2198-2207

Subject Terms: [SDV]Life Sciences [q-bio], chemical and pharmacologic phenomena, hemic and immune systems, ddc:616.07, Age Factors, Breast Neoplasms / immunology, Breast Neoplasms / metabolism, Breast Neoplasms / mortality, Breast Neoplasms / pathology, Carcinoma, Lobular / immunology, Carcinoma, Lobular / metabolism, Carcinoma, Lobular / mortality, Carcinoma, Lobular / pathology, Female, Humans, Lymphocytes, Tumor-Infiltrating / immunology, Lymphocytes, Tumor-Infiltrating / pathology, Middle Aged, Prognosis, Receptor, ErbB-2 / metabolism, Receptors, Estrogen / metabolism, Receptors, Progesterone / metabolism, Retrospective Studies, Survival Rate, Pathology and Forensic Medicine, Invasive Lobular Breast Carcinoma, Survival analysis, Medicine, business.industry, business, Invasive lobular carcinoma, medicine.disease, Tumor-infiltrating lymphocytes, Nottingham Prognostic Index, Internal medicine, medicine.medical_specialty, Lymph node, medicine.anatomical_structure, Pathology, Biomarker (medicine), Oncology, Estrogen receptor, skin and connective tissue diseases

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e706a06496cec3a93a064f39656fada
https://hal.archives-ouvertes.fr/hal-03032297

4
Type I IFN Receptor Signaling Controls IL7-Dependent Accumulation and Activity of Protumoral IL17A-Producing γδT Cells in Breast Cancer

Authors: Christophe Paget, Maya Hassane, Christelle Faveeuw, Daphnée Soulard, François Trottein, Sébastien Fleury, Emmanuel C. Patin, David Dombrowicz

Contributors: Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 (RNMCD), Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), European Genomic Institute for Diabetes - FR 3508 (EGID), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre National de la Recherche Scientifique (CNRS), Université Libanaise, Centre d’Etude des Pathologies Respiratoires (CEPR), UMR 1100 (CEPR), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), This work was supported by the recurrent annual financial support from INSERM. E.C. Patin was supported by a post-doctoral fellowship from the French Institute of Cancer (INCa). C. Paget, S. Fleury, D. Dombrowicz, and C. Faveeuw were supported by INSERM. F. Trottein was supported by CNRS. M. Hassane was the recipient of a doctoral fellowship from the AZM Foundation. We thank the Pasteur Lille animal facility for excellent mouse husbanding. We also thank the BICeL flow cytometry core facility for technical assistance. This work was supported by the 'Institut National du Cancer' (INCa, PLBIO14-155, recipient: C. Paget)., Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL], Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires [RNMCD - U1011], Centre d’Etude des Pathologies Respiratoires (CEPR), UMR 1100 [CEPR], Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Université de Lille-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Lille, Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires (RNMCD - U1011)

Source: Cancer Research
Cancer Research, 2018, 78 (1), pp.195-204. ⟨10.1158/0008-5472.CAN-17-1416⟩
Cancer Research, American Association for Cancer Research, 2018, 78 (1), pp.195-204. ⟨10.1158/0008-5472.CAN-17-1416⟩

Subject Terms: MESH: Animals, MESH: Breast Neoplasms/immunology, MESH: Mice, Inbred BALB C, MESH: Mice, Inbred C57BL, MESH: Receptor, Interferon alpha-beta/genetics, MESH: Receptor, Interferon alpha-beta/immunology, MESH: Receptor, Interferon alpha-beta/metabolism, MESH: Receptors, Antigen, T-Cell, gamma-delta/metabolism, MESH: Signal Transduction, MESH: T-Lymphocyte Subsets/immunology, MESH: T-Lymphocyte Subsets/metabolism, MESH: Tumor Necrosis Factor Receptor Superfamily, Member 7/genetics, MESH: Breast Neoplasms/metabolism, MESH: Tumor Necrosis Factor Receptor Superfamily, Member 7/metabolism, MESH: Breast Neoplasms/pathology, MESH: Female, MESH: Interleukin-17/genetics, MESH: Interleukin-17/metabolism, MESH: Interleukin-7/metabolism, MESH: Lymphocytes, Tumor-Infiltrating/metabolism, MESH: Lymphocytes, Tumor-Infiltrating/pathology, [SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity, Cancer Research, Oncology, Metastasis, medicine.disease, medicine, Tumor microenvironment, Breast cancer, Biology, Cancer, Angiogenesis, Immune system, T-cell receptor, Immunology, Cancer research, Tumor progression, [SDV]Life Sciences [q-bio]

File Description: application/octet-stream

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e09b4212303852f721fd35a700bae12
https://www.hal.inserm.fr/inserm-02436039

5
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno- Oncology Biomarker Working Group on Breast Cancer

Authors: Dieci, Maria Vittoria, Radosevic-Robin, Nina, Fineberg, Susan, Van den Eynden, Gert, Ternes, Nils, Pénault-Llorca, Frederique, Pruneri, Giancarlo, D'Alfonso, Timothy TM, Demaria, Sandra, Castaneda, Carlos, Sanchez, Joselyn, Badve, Sunil, Michiels, Stefan, Bossuyt, Veerle Ilse Julie, Rojo, Federico, Singh, Baljit, Nielsen, Torsten, Viale, Giuseppe, Kim, Seong-Rim, Hewitt, Stephen M, Wienert, Stephan, Loibl, Sibylle, Rimm, David D.L., Symmans, Fraser, Denkert, Carsten, Adams, Sylvia, Loi, Sherene, Salgado, Roberto, International Immuno-Oncology Biomarker Working Group on Breast Cancer

Contributors: Universita degli Studi di Padova, Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER, Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), European Institute of Oncology [Milan] (ESMO), Ctr Biomol Struct & Org, University of Maryland [College Park], University of Maryland System-University of Maryland System, Equipe de recherche sur les traitements individualisés des cancers (ERTICa), Université d'Auvergne - Clermont-Ferrand I (UdA), Méthodologie et épidémiologie clinique en oncologie moléculaire (U1018 (Équipe 2)), Institut Gustave Roussy (IGR)-Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Institut National de la Santé et de la Recherche Médicale (INSERM), Division of Pathology and Laboratory Medicine, Università degli Studi di Milano [Milano] (UNIMI)-European Institute of Oncology [Milan] (ESMO), Charité, Institute of Pathology, Translational Tumorpathology Unit, Breast Cancer Translational Research Laboratory, Institut Jules Bordet [Bruxelles], Faculté de Médecine [Bruxelles] (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB)-Faculté de Médecine [Bruxelles] (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Gustave Roussy (IGR), Università degli Studi di Milano = University of Milan (UNIMI)-European Institute of Oncology [Milan] (ESMO), Università degli Studi di Padova = University of Padua (Unipd)

Source: Seminars in Cancer Biology
Seminars in Cancer Biology, Elsevier, 2018, 52, pp.16-25. ⟨10.1016/j.semcancer.2017.10.003⟩
Seminars in Cancer Biology, Elsevier, 2017, ⟨10.1016/j.semcancer.2017.10.003⟩
Seminars in Cancer Biology, 2017, ⟨10.1016/j.semcancer.2017.10.003⟩
Seminars in Cancer Biology, 2018, 52, pp.16-25. ⟨10.1016/j.semcancer.2017.10.003⟩
Seminars in cancer biology, 52 (Pt 2

Subject Terms: [SDV.CAN]Life Sciences [q-bio]/Cancer, chemical and pharmacologic phenomena, hemic and immune systems, Tumor-infiltrating lymphocytes, Residual disease, Breast cancer, Ductal carcinoma in situ, Neoadjuvant, Residual cancer burden, Cancer Research, Ductal carcinoma, Trastuzumab, medicine.drug, medicine, Neoadjuvant therapy, medicine.medical_treatment, business.industry, business, Tumor marker, Minimal residual disease, medicine.disease, Oncology, medicine.medical_specialty, Internal medicine, Carcinoma in situ, Cancer staging, breast cancer, ductal carcinoma in situ, neoadjuvant, residual cancer burden, residual disease, Sciences bio-médicales et agricoles, Biomarkers, Tumor -- immunology, Breast Neoplasms -- immunology, Carcinoma in Situ -- immunology, Female, Humans, Lymphocytes, Tumor-Infiltrating -- immunology, Medical Oncology -- methods, Neoadjuvant Therapy -- methods, Neoplasm, Residual -- immunology

File Description: 1 full-text file(s): application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dd3859cf12f93459c10ccfceebeba47
https://hal.uca.fr/hal-02387991

6
Autocrine adenosine regulates tumor polyfunctional CD73+CD4+ effector T cells devoid of immune checkpoints

Authors: Marion Bossennec, Olivier Tredan, Isabelle Durand, Christelle Machon, Jérôme Guitton, Camilla Jandus, Julien Faget, Nicolas Chopin, David Bauché, Céline Rodriguez, Nicolas Gourdin, Bertrand Dubois, Christine Ménétrier-Caux, Christophe Caux, Selena Vigano, Julien C. Marie, Pedro Romero

Contributors: Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université de Lausanne (UNIL), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Institut des Sciences Pharmaceutiques et Biologiques (ISPB), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon, German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Department of Medical Oncology [Lyon], Centre Léon Bérard [Lyon], Centre de Recherche en Cancérologie de Lyon (CRCL), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CRLCC Val d'Aurelle - Paul Lamarque-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Lausanne = University of Lausanne (UNIL)

Source: Cancer Research, Vol. 78, No 13 (2018) pp. 3604-3618
Cancer Research
Cancer Research, American Association for Cancer Research, 2018, 78 (13), pp.3604-3618. ⟨10.1158/0008-5472.CAN-17-2405⟩
Cancer research, vol. 78, no. 13, pp. 3604-3618

Subject Terms: 5'-Nucleotidase/metabolism, Adenosine/metabolism, Antineoplastic Agents, Immunological/pharmacology/therapeutic use, Apyrase/metabolism, Breast Neoplasms/drug therapy/immunology/pathology, Costimulatory and Inhibitory T-Cell Receptors/antagonists & inhibitors/metabolism, Drug Resistance, Neoplasm/immunology, Female, GPI-Linked Proteins/metabolism, Humans, Interleukin-17/metabolism, Lymphocytes, Tumor-Infiltrating/immunology/metabolism, Ovarian Neoplasms/drug therapy/immunology/pathology, T-Lymphocytes, Helper-Inducer/immunology/metabolism, Regulatory/immunology/metabolism, Tumor Escape/immunology, chemical and pharmacologic phenomena, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, [SDV.CAN]Life Sciences [q-bio]/Cancer, Antineoplastic Agents, Immunological/pharmacology, Antineoplastic Agents, Immunological/therapeutic use, Breast Neoplasms/drug therapy, Breast Neoplasms/immunology, Breast Neoplasms/pathology, Costimulatory and Inhibitory T-Cell Receptors/antagonists & inhibitors, Costimulatory and Inhibitory T-Cell Receptors/metabolism, Drug Resistance, Neoplasm/immunology, Lymphocytes, Tumor-Infiltrating/immunology, Lymphocytes, Tumor-Infiltrating/metabolism, Ovarian Neoplasms/drug therapy, Ovarian Neoplasms/immunology, Ovarian Neoplasms/pathology, T-Lymphocytes, Helper-Inducer/immunology, T-Lymphocytes, Helper-Inducer/metabolism, T-Lymphocytes, Regulatory/immunology, T-Lymphocytes, Regulatory/metabolism, Cancer Research, Oncology, Immune checkpoint, Immune system, CXCR3, Cancer research, Effector, Chemistry, Autocrine signalling, Interleukin 22, C-C chemokine receptor type 6, Tumor Escape

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8375fbfa2c51d166ee5ae1ba8adac560
https://archive-ouverte.unige.ch/unige:136010

7
Standardized assessment of tumor-infiltrating lymphocytes in breast cancer:an evaluation of inter-observer agreement between pathologists

Authors: Tramm, Trine, Di Caterino, Tina, Jylling, Anne-Marie B, Lelkaitis, Giedrius, Lænkholm, Anne-Vibeke, Ragó, Péter, Tabor, Tomasz P, Talman, Maj-Lis M, Vouza, Emmanouela

Source: Tramm, T, Di Caterino, T, Jylling, A-M B, Lelkaitis, G, Lænkholm, A-V, Ragó, P, Tabor, T P, Talman, M-L M, Vouza, E & Scientific Committee of Pathology, Danish Breast Cancer Group (DBCG) 2018, ' Standardized assessment of tumor-infiltrating lymphocytes in breast cancer : an evaluation of inter-observer agreement between pathologists ', Acta Radiologica Open, vol. 57, no. 1, pp. 90-94 . https://doi.org/10.1080/0284186X.2017.1403040

Subject Terms: Breast Neoplasms/immunology, Carcinoma, Ductal, Breast/immunology, Carcinoma, Lobular/immunology, Female, Humans, Lymphocytes, Tumor-Infiltrating/pathology, Pathology, Clinical/standards, Reproducibility of Results, Staining and Labeling, chemical and pharmacologic phenomena, hemic and immune systems

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=od______3062::a9cf4e21786ae7ce86433b0de096a1b1
https://findresearcher.sdu.dk:8443/ws/files/141956139/Intra_and_inter_observer_agreement_and_reliability_of_bone_mineral_density_measurements_around_acetabular_cup.pdf

8
Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists

Authors: Anne-Marie B Jylling, Emmanouela Vouza, Trine Tramm, Tina Di Caterino, Tomasz Piotr Tabor, Péter Ragó, Anne Vibeke Lænkholm, Maj-Lis Møller Talman, Giedrius Lelkaitis

Source: Scientific Committee of Pathology, Danish Breast Cancer Group (DBCG) 2018, ' Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists ', Acta Oncologica, vol. 57, no. 1, pp. 90-94 . https://doi.org/10.1080/0284186X.2017.1403040

Subject Terms: Breast Neoplasms/immunology, Carcinoma, Ductal, Breast/immunology, Carcinoma, Lobular/immunology, Female, Humans, Lymphocytes, Tumor-Infiltrating/pathology, Pathology, Clinical/standards, Reproducibility of Results, Staining and Labeling, chemical and pharmacologic phenomena, hemic and immune systems, Radiology, Nuclear Medicine and imaging, Oncology, Hematology, General Medicine, Text mining, business.industry, business, Inter observer agreement, MEDLINE, Pathology, medicine.medical_specialty, medicine, Breast cancer, medicine.disease, Carcinoma, Standardized test, Breast pathology, Internal medicine, Tumor-infiltrating lymphocytes

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e18e405ec4f636a9bbd180966a5037ba
https://pure.au.dk/portal/da/publications/standardized-assessment-of-tumorinfiltrating-lymphocytes-in-breast-cancer-an-evaluation-of-interobserver-agreement-between-pathologists(c45137f2-da41-4977-afb5-82bf4042ec41).html

9
Prognostic markers in oropharyngeal squamous cell carcinoma : focus on CD70 and tumour infiltrating lymphocytes

Authors: Sylvie Rottey, Karen Zwaenepoel, Philippe Deron, Astrid De Meulenaere, Fréderic Duprez, Liesbeth Ferdinande, Sandrine Aspeslagh, Tijl Vermassen

Contributors: Medical Oncology

Source: Pathology

Subject Terms: Human medicine, chemical and pharmacologic phenomena, hemic and immune systems, Pathology and Forensic Medicine, Proportional hazards model, Confidence interval, Oncology, medicine.medical_specialty, medicine, business.industry, business, Biomarker (medicine), T cell, medicine.anatomical_structure, FOXP3, CD70, CD3, biology.protein, biology, Internal medicine, CD8, Aged, aged, 80 and over, Breast Neoplasms/immunology, CD27 Ligand/immunology, CD4-Positive T-Lymphocytes/pathology, CD8-Positive T-Lymphocytes/immunology, Carcinoma, Squamous Cell/diagnosis, Female, Head and Neck Neoplasms/diagnosis, Humans, Lymphocytes, Tumor-Infiltrating/immunology, Male, Middle Aged, Mouth Neoplasms/immunology, Oropharyngeal Neoplasms/diagnosis, Prognosis, Squamous Cell Carcinoma of Head and Neck

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e64aff558353e02b4a32956cea6b2c4e

10
Dendritische Zellen in der Immuntherapie gegen Tumoren: Untersuchungen zu der durch dendritische Zellen vermittelten spezifischen Immunantwort beim Mammakarzinom und vom Tumor ausgehende immunsupprimierende Einflüsse

Authors: Matthes, Constanze

Subject Terms: Breast Neoplasms-immunology, Breast Neoplasms-therapy, Immunotherapy-methods, Dendritic Cells, Academic Dissertations

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_________::0cffb96661950052725e05177664f784

11
Tumor-specific killer cells in paraneoplastic cerebellar degeneration

Authors: Armin Bender, Robert B. Darnell, Loise M. Francisco, Matthew L. Albert, Jennifer C. Darnell, Nina Bhardwaj

Contributors: Laboratory of Molecular Neuro-oncology, Howard Hughes Medical Institute (HHMI)-Rockefeller University [New York], Laboratory of Cellular Physiology and Immunology, Rockefeller University [New York], Support from the Department of Defense (Breast Cancer Research Award #DAMD017-94-J-4277), the National Multiple Sclerosis Society (PP0507), and the NIH Medical Scientist Training Program grant (GM-07739) is acknowledged.Clinical work at the RU Hospital GCRC was supported through grant M01 RR00102, and approved by institutional IRB #RDA-148. N.B. was supported by NIH grant AI-39516 and grants from the SLE Foundation., Vougny, Marie-Christine

Source: Nature Medicine
Nature Medicine, Nature Publishing Group, 1998, 4 (11), pp.1321-1324. ⟨10.1038/3315⟩

Subject Terms: MESH: Animals, MESH: Apoptosis/radiation effects, MESH: Histocompatibility Antigens Class I/immunology, MESH: Humans, MESH: Immunity, Cellular, MESH: Killer Cells, Natural/immunology, MESH: Lymphoid Tissue/immunology, MESH: Mice, MESH: Nerve Degeneration/immunology, MESH: Ovarian Neoplasms/immunology, MESH: Paraneoplastic Syndromes/immunology, MESH: T-Lymphocyte Subsets/immunology, MESH: T-Lymphocytes, Cytotoxic/immunology, MESH: Ultraviolet Rays, MESH: Breast Neoplasms/immunology, MESH: Cells, Cultured, MESH: Cerebellar Diseases/immunology, MESH: Cytotoxicity, Immunologic, MESH: Female, MESH: HeLa Cells, [SDV.IMM]Life Sciences [q-bio]/Immunology, chemical and pharmacologic phenomena, [SDV.IMM] Life Sciences [q-bio]/Immunology, General Biochemistry, Genetics and Molecular Biology, General Medicine, Paraneoplastic cerebellar degeneration, medicine.disease, medicine, MHC class I, biology.protein, biology, CTL, Immunology, Immunity, Immune system, Cytotoxic T cell, Lymphatic system, Antigen

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8cec53986c42efabc6d820501218acb
https://hal-pasteur.archives-ouvertes.fr/pasteur-01402438

14
Correlation study between osteoporosis and hematopoiesis in the context of adjuvant chemotherapy for breast cancer

Authors: Jérôme Pasquier, Olivier Lamy, Anne-Laure Nicoulaz, Frédérica Schyrr, Olaia Naveiras, Anita Wolfer

Source: Annals of Hematology
Annals of hematology, vol. 97, no. 2, pp. 309-317

Subject Terms: Hematology, General Medicine, Internal medicine, medicine.medical_specialty, medicine, Febrile neutropenia, medicine.disease, Context (language use), Oncology, Osteoporosis, Bone marrow, medicine.anatomical_structure, Bone mineral, business.industry, business, Trabecular bone score, Anemia, Breast cancer, Original Article, Hematopoiesis, Osteoblast, T-score, TBS, Chemotherapy, Bone marrow microenvironment, Bone marrow adipocytes, Stress hematopoiesis, Neutrophil, Platelet, Graded toxicity of chemotherapy, Absorptiometry, Photon, Adipocytes/drug effects, Adipocytes/immunology, Adipocytes/pathology, Adult, Aged, Antineoplastic Agents/administration & dosage, Antineoplastic Agents/adverse effects, Blood Platelets/drug effects, Blood Platelets/immunology, Blood Platelets/pathology, Body Mass Index, Bone Density/drug effects, Bone Density/immunology, Bone Diseases, Metabolic/complications, Bone Diseases, Metabolic/diagnostic imaging, Bone Diseases, Metabolic/drug therapy, Bone Diseases, Metabolic/immunology, Bone Marrow Cells/drug effects, Bone Marrow Cells/immunology, Bone Marrow Cells/pathology, Breast Neoplasms/complications, Breast Neoplasms/diagnostic imaging, Breast Neoplasms/drug therapy, Breast Neoplasms/immunology, Cell Count, Chemotherapy, Adjuvant, Female, Hematopoiesis/drug effects, Hematopoiesis/immunology, Humans, Lumbar Vertebrae/diagnostic imaging, Lumbar Vertebrae/drug effects, Lumbar Vertebrae/immunology, Lumbar Vertebrae/pathology, Middle Aged, Neutropenia/chemically induced, Neutropenia/diagnostic imaging, Neutropenia/immunology, Neutropenia/pathology, Neutrophils/drug effects, Neutrophils/immunology, Neutrophils/pathology, Osteoblasts/drug effects, Osteoblasts/immunology, Osteoblasts/pathology, Osteoporosis/complications, Osteoporosis/diagnostic imaging, Osteoporosis/drug therapy, Osteoporosis/immunology, Retrospective Studies

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a67310f9ac0399e5dc93c198394d281
https://infoscience.epfl.ch/record/258592

15
Electronic Resource
Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer

Source: Frontiers in Immunology

Index Terms: Animals, Cell Differentiation, Co-Repressor Proteins/metabolism, Cytokines/metabolism, Disease Models, Animal, Flavin-Adenine Dinucleotide/metabolism, Histone Demethylases/antagonists & inhibitors, Humans, Macrophage Activation, Macrophages/immunology, Mice, Nerve Tissue Proteins/metabolism, Phenelzine/pharmacology, RAW 264.7 Cells, RNA, Small Interfering/genetics, Snail Family Transcription Factors/metabolism, Th1 Cells/immunology, Triple Negative Breast Neoplasms/immunology, Tumor Microenvironment, Contribution to Journal

URL: https://eprints.qut.edu.au/210042/1/fimmu_10_01351.pdf
https://eprints.qut.edu.au/210042/1/fimmu_10_01351.pdf
doi:10.3389/fimmu.2019.01351
Tan, Abel H Y, Tu, WenJuan, McCuaig, Robert, Hardy, Kristine, Donovan, Thomasina, Tsimbalyuk, Sofiya, Forwood, Jade K, & Rao, Sudha (2019) Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer. Frontiers in Immunology, 10, Article number: 1351.

Search Tools: Get RSS Feed — Email this Search